The integration of diverse clinical modalities such as medical imaging and the tabular data extracted from patients' Electronic Health Records (EHRs) is a crucial aspect of modern healthcare. Integrative analysis of multiple sources can provide a com...
Alzheimer's disease (AD) is a progressive neurological condition characterized by cognitive decline, memory loss, and aberrant behaviour. It affects millions of people globally and is one of the main causes of dementia. The neurodegenerative conditio...
Convolutional neural networks (CNNs) and mammalian visual systems share architectural and information processing similarities. We leverage these parallels to develop an in-silico CNN model simulating diseases affecting the visual system. This model a...
European journal of nuclear medicine and molecular imaging
Feb 18, 2025
PURPOSE: Center-specific effects in PET brain scans arise due to differences in technical and procedural aspects. This restricts the merging of data between centers and introduces source-specific bias.
BACKGROUND: Since its emergence in 2019, COVID-19 has become a global epidemic. Several studies have suggested a link between Alzheimer's disease (AD) and COVID-19. However, there is little research into the mechanisms underlying these phenomena. The...
Recently, deep learning-based medical image classification models have made substantial advancements. However, many existing models prioritize performance at the cost of efficiency, limiting their practicality in clinical use. Traditional Convolution...
Alzheimer's Disease (AD) is a progressive condition of a neurological brain disorder recognized by symptoms such as dementia, memory loss, alterations in behaviour, and impaired reasoning abilities. Recently, many researchers have been working to dev...
International journal of molecular sciences
Feb 16, 2025
The development of BACE-1 (β-site amyloid precursor protein cleaving enzyme 1) inhibitors is a crucial focus in exploring early treatments for Alzheimer's disease (AD). Recently, graph neural networks (GNNs) have demonstrated significant advantages i...
OBJECTIVES: Dementia can change oculomotor behavior, which is detectable through eye-tracking. This study aims to systematically review and conduct a meta-analysis of current literature on the intersection between eye-tracking and artificial intellig...
International journal of molecular sciences
Feb 14, 2025
Approximately 50% of Alzheimer's disease (AD) patients develop psychotic symptoms, leading to a subtype known as psychosis in AD (AD + P), which is associated with accelerated cognitive decline compared to AD without psychosis. Currently, no FDA-appr...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.